Ylva Ginsberg, MD, PhD
Ylva Ginsberg, MD, PhD
Karolinska Institute
Department of Medical Epidemiology and Biostatistics
Karolinska Institutet, SE 171-77
Stockholm
Sweden
Papers:
16.1
Methylphenidate Hydrochloride Modified Release for Adults with ADHD: A 40-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy, and Safety Study
16.2
Methylphenidate Hydrochloride Modified Release in Adults with ADHD: Self-Rated, Observer-Rated, and Physician-Rated Assessments Show Consistently Significant Improvement Compared to Placebo